Trial Profile
A Multi-Center Open-Label Study Evaluating the Cytokine and Eyelid Margin Bacterial Load Levels of Subjects Diagnosed With Chronic Blepharitis Following Dosing With AzaSite (Azithromycin Ophthalmic Solution) 1%
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Azithromycin (Primary)
- Indications Bacterial infections; Infectious blepharitis
- Focus Therapeutic Use
- Sponsors Merck & Co
- 25 Nov 2008 Status changed from active, no longer recruiting to completed, as reported in ClinicalTrial.gov record.
- 24 Apr 2008 Status changed from recruiting to in progress.
- 25 Mar 2008 Status changed from intitiated to recruiting.